[Immunization against diphtheria and tetanus in children with severe neurological disorders].
In the clinical department of the Institute for Sera and Vaccines 260 children with serious neurological diseases were immunized with Alditeana and Alteana. After immunization an undesirable reaction was recorded in 3.1% of the immunized children. Mostly recurrence or potentiation of clinical manifestations of the basic neurological disease of the child was involved. Investigation of the anamnestic data revealed several serious undesirable reactions after vaccination with Alditepera in a health centre for child patients.
Stehlíková
J
J
Ustav sér a ockovacích látek, Praha.
Bergmannová
V
V
Domorázková
E
E
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004165:Diphtheria / Q000517:prevention & control*; D004168:Diphtheria Toxoid / Q000009:adverse effects*; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000009:adverse effects*; D004338:Drug Combinations; D006801:Humans; D007223:Infant; D009422:Nervous System Diseases / Q000276:immunology; D013742:Tetanus / Q000517:prevention & control*; D013745:Tetanus Toxoid / Q000009:adverse effects*
D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D004338:Drug Combinations; D013745:Tetanus Toxoid